Study guide
9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers
Utah MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC
1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline
2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel
2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel
3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment
3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement
4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing
4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records
5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards
6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration
6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting
7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs
7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program
8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah
8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security
9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database
9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)
10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products
10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales
11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery
11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients
12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs
12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards
13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation
13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits
9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers
Key Takeaways Explain This Topic AI
A Utah Schedule III or IV prescription may be filled only within six months of issuance and refilled no more than five times, unless the practitioner renews it (Utah Code § 58-37-304(6)(e)).
A Utah Schedule V prescription may be refilled as directed, but not more than one year after issuance unless renewed (Utah Code § 58-37-304(6)(f)); this includes gabapentin.
Utah bars refilling a controlled substance until 80% of the previous fill should have been used as directed (R156-37-603(6)).
If a Utah prescriber leaves refills blank on a Schedule III–V prescription, no refills are authorized (R156-37-603(4)(a)).
Schedule III–V refill information may be transferred once between pharmacies, or up to the maximum refills if they share a real-time online database, and transfers must be communicated directly between two licensed pharmacists (21 CFR 1306.25).
Last updated: September 2026
9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers
Blueprint items 2.1 (refill authority) and 3.2 (transferring prescription information) come together for Schedules III–V.
Refill and expiration limits
Schedule Utah rule Federal rule
III and IV Filled only within six months of issuance; may not be refilled more than six months after issuance or more than five times unless renewed (§ 58-37-304(6)(e); R156-37-603(5)(a)) Same (21 CFR 1306.22)
V Refilled as the prescription directs, but not more than one year after issuance unless renewed (§ 58-37-304(6)(f); R156-37-603(5)(b)) Refills as authorized; no federal time limit
All CS Refills after the original prescription term expires require a new prescription (R156-37-603(8)) —
No refill instruction means no refills. If the prescriber does not document refill intentions on a CIII–V prescription, no refills are authorized (R156-37-603(4)(a)).
Specific directions are required. A CS prescription may not be issued or dispensed without specific instructions on how and when to use it (R156-37-603(7)).
Gabapentin follows the Schedule V one-year rule in Utah (Section 8.1).
Acute opiates: the 7-day acute limit applies to Schedule III opiates too, such as acetaminophen with codeine (§ 58-37-304(6)(d)).
The 80% rule (R156-37-603(6))
"A refill may not be dispensed until sufficient time has passed since the date of the last dispensing that 80% of the medication in the previous dispensing should have been consumed if taken according to the prescribing practitioner's instruction."
Example: 30 tablets of alprazolam 0.5 mg, one tablet daily, dispensed June 1. Eighty percent of 30 days is 24 days, so the earliest refill is June 25 . Utah's 80% rule applies to controlled substances. For eye drops , the separate 70% rule applies (§ 58-17b-608.1(2)).
Refill records and partial refills (federal)
Each refill is recorded with the date , quantity , and the identity of the dispensing pharmacist (21 CFR 1306.22). Utah allows prescription records to be kept electronically if the original prescription (including telephone prescriptions) is kept in a physical file and the system gives immediate retrieval of CIII–IV refill information (R156-37-602(4)).
Partial refills of CIII–V are allowed if each is recorded as a refill, the total does not exceed the quantity prescribed, and nothing is dispensed more than six months after issuance (21 CFR 1306.23).
Transferring controlled substance prescriptions
Utah incorporates the federal transfer rule: "Prescription orders for controlled substances including prescription transfers shall be handled in accordance with 21 CFR 1306.25" (R156-17b-612(1)).
Feature Rule
Refill transfers, Schedules III–V One-time transfer between pharmacies, unless the pharmacies share a real-time, online database , in which case refills may be transferred up to the maximum refills authorized (21 CFR 1306.25(a); R156-17b-613(10))
Who communicates The transfer must be communicated directly between two licensed pharmacists (21 CFR 1306.25(a)(1))
Transferring pharmacy Records the transfer and invalidates the prescription (for example, writes "VOID"), noting the receiving pharmacy, its DEA number, the receiving pharmacist, the date, and the transferring pharmacist
Receiving pharmacy Writes "transfer" and records the original issue date, original dispensing date, refills authorized and remaining, dates and locations of prior refills, the transferring pharmacy and its DEA number and prescription number, and the transferring pharmacist
Unfilled electronic CS prescriptions (CII–V) May be transferred once between pharmacies for initial dispensing, pharmacist to pharmacist, since DEA's 2023 rule. Utah software must support this since July 1, 2024 (§ 58-37-302(3)).
Retention Both records kept five years in Utah (R156-17b-612(5)(b); R156-37-602(3))
Utah's broader transfer rule for legend drugs lets a pharmacist, intern, technician (at the on-duty pharmacist's discretion), or DMP transfer, and says staff may not refuse to transfer information on a patient's behalf (R156-17b-612(5)). For controlled substances , the federal requirement that two licensed pharmacists communicate the transfer controls. See Section 10.3 for legend-drug transfers.
Scenarios
Sixth refill request. A lorazepam prescription dated January 10 authorized five refills, and all five have been dispensed. On May 15 the patient asks for more. No refills remain, so a new prescription is needed.
Seven months later. A CIV prescription dated January 10 still shows two refills on August 15. Refills may not be dispensed more than six months after issuance, so they expired July 10.
Transfer request. A patient asks to move remaining clonazepam refills to an unaffiliated pharmacy. One transfer is allowed, pharmacist to pharmacist. Once transferred, the refills cannot be transferred again to a third pharmacy.
Exam strategy
For any Schedule III–V refill question, check four limits in order:
- time : 6 months for CIII–IV, 1 year for CV;
- count : no more than 5 refills for CIII–IV;
- pace : Utah's 80% rule; and
authorization : a blank refill field means zero.
For transfers, ask whether the pharmacies share a real-time database and whether the transfer is pharmacist to pharmacist.